What this opportunity is
The Department of State is seeking a non-competitive increase in funding and scope for the CHEGAR project, which focuses on the transportation and distribution of healthcare commodities in Mozambique, particularly for HIV, malaria, maternal and child health, and tuberculosis programs. This opportunity is relevant for small businesses with capabilities in logistics and healthcare supply chain management, as it involves a transition of services from the Global Health Supply Chain project to CHEGAR. As this is a justification notice, interested parties should track the developments rather than prepare to bid immediately.
Analysis by Mindy, grounded in the SAM.gov notice.
Description
SBU - CONTRACTING AND ACQUISITIONS
-- 1 of 15 --
Page 2 of 15
The Laboratory Sample Transportation (LST) and distribution from c entral to
provincial/intermediate level is currently implemented by the project Global Health Supply Chain
– Procurement and Supply Management (GHSC-PSM) and is expected to end on March 31, 2027.
These activities are proposed to start on/around November 1,2026 to avoid disruption of services
which would allow for 2-4 months to ensure a smooth transition from GHSC-PSM to CHEGAR.
This is a request to approve a non-competitive increase in contract funding and scope of work for
contract number 72065621C00001 with Africa Global Logistics (AGL) , in support of the
Commodities for Health Guaranteed Access and Reliability (CHEGAR ) and the President’s
Emergency Plan for AIDS (PEPFAR) programs to transition the LST and central distribution
activities from (GHSC-PSM)
The CHEGAR project plays a pivotal role in transportation and distribution of healthcare
commodities to the last mile in Mozambique t hrough strategic engagement with the private
sector. Operating across eleven provinces and around 1900 delivery sites, the program improves
the availability of prevention, testing, and treatment commodities, ensuring the accessibility of
healthcare commodities nationwide, particularly in underserved and hard-to-reach areas. These
efforts are critical to achieving lasting health outcomes and supporting national HIV, Malaria,
MCHN and TB programs. CHEGAR is implemented by AGL which has proven experience in
the distribution and sample transport activities.
A modification to increase the funding and scope of work to the CHEGAR contract will solidify
the transport activities ov ersight from USAID to the Department of State (DOS), which has
already been effectively implemented. This adjustment will ensure the program’s continued
effectiveness and sustainability, preserving a mature, robust, and functional initiative that aligns
with the U.S. Government’s commitments to PEPFAR and the national HIV and TB response.
The increase will maintain essential services such as antiretrovirals (ARVs), malaria treatments,
rapid diagnostics tests for HIV and malaria, maternal and child health supplies, surgical materials,
laboratory commodities, vaccines, laboratory sample transportation and distribution from central
level to the provincial/intermediate level
The current contract expires on April 01, 2028.
This action is critical to prevent a lapse in services that would pose an immediate risk to public
health and human life in Mozambique.
SECTION 3: DESCRIPTION OF SUPPLIES/SERVICES REQUIRED TO MEET THE AGENCY’S NEEDS
SBU - CONTRACTING AND ACQUISITIONS
-- 2 of 15 --
Page 3 of 15
Mozambique carries a high burden of HIV and tuberculosis (TB), with a national HIV
prevalence of 12.5% and one of the highest rates of multidrug-resistant TB globally. Timely,
accurate, and accessible diagnostic services are critical to achieving epidemic control and
improving health outcomes for affected populations.
In response to these challenges, the Ministry of Health (MISAU), in collaboration with the
United States Government (USG)—primarily through PEPFAR—has made significant
investments to expand and strengthen the country's diagnostic infrastructure. The USG
currently allocates nearly $400 million annually to Mozambique’s health sector, with
approximately $50 million dedicated specifically to HIV and TB diagnostic efforts.
These investments have yielded notable gains, including increased access to viral load (VL) and
early infant diagnosis (EID) testing, and the broader deployment of GeneXpert platforms across
the country. However, persistent challenges continue to hinder the diagnostic network’s
effectiveness. These include inefficiencies in sample transport, shortages of skilled personnel,
inadequate cold chain systems, and prolonged turnaround times for test results. Rural and hard-
to-reach areas remain especially underserved.
The LST was being implemented by AGL through a USAID contract, under the project name
AMOSTRA (Adapting and Modifying Optimized Sample Transport Routes for Achieving
Impact), which was terminated during the Stop Work Order in March of 2025, and transitioned
under the management of GHSC-PSM with the current name Laboratory Sample
Transportation (LST). During this process AGL was shifted to a subcontractor but is still
providing overall management of the activity. Transitioning this activity back to AGL would
therefore create minimal disruption. This activity will be operated under the supervision of the
GRM and will aim at increasing access to diagnostic testing while improving the timeliness of
diagnostic test results by ensuring shortened turnaround times between specimen collection,
drop-offs, and return of results. The activity will also assure the quality of diagnostic testing
through proper handling of specimens and through support of a national platform for specimen
transport reporting, monitoring and coordination that leads to continuous quality improvement
of specimen transport.
SBU - CONTRACTING AND ACQUISITIONS
-- 3 of 15 --
Page 4 of 15
In addition to the LST, GHSC-PSM also implements the distribution from central to
provincial/intermediate, which involves distribution of commodities funded by the USG
(ARVs, malaria treatment, laboratory consumables and Rapid Diagnostic Tests, as well as TB
commodities when space is available) from central to provincial/intermediate level.
CHEGAR is well positioned to take on these distribution activities, given their current role in
the last mile distribution (provincial/intermediate to health facility level) and overall expertise
in transportation services
The Commodities for Health Ensuring Guaranteed Access and Reliability (CHEGAR) activity
is designed to establish a reliable and efficient transportation system for medical commodities
in Mozambique. Through strategic engagement with the private sector, CHEGAR p…
Source: SAM.gov, as posted. Verify the current solicitation before responding.